<DOC>
	<DOCNO>NCT00115648</DOCNO>
	<brief_summary>The purpose study determine extend antiretroviral regimen give infant first 14 week age would decrease breast milk transmission HIV .</brief_summary>
	<brief_title>Extended Infant Post-exposure Prophylaxis With Antiretrovirals Reduce Postnatal HIV Transmission</brief_title>
	<detailed_description>This three-arm randomized , open label , clinical trial evaluate effectiveness two extend regimen antiretrovirals compare infant single dose nevirapine plus AZT give twice daily 1 week ( comparison regimen ) . All infant receive comparison regimen birth randomize birth start either one two extend regimen first week . The extended regimen nevirapine daily nevirapine plus AZT daily - regimen give age 14 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Had give birth within last 24 hour Ability willingness give inform consent HIV test enrollment study Willing receive HIV result HIV infect Planning deliver give birth study clinic Willing come back followup visit 2 year postnatally Resident Blantyre city suburbs HIV negative Women discordant HIV result Women indicate breastfeed time delivery Inability unwillingness follow inclusion requirement Newborn lifethreatening condition Women previously enrol study second pregnancy reenroll</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>MTCT</keyword>
	<keyword>Infants</keyword>
	<keyword>africa</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>